Dr. Nan Cheng M.D.
Founder, Irvine Headache Care
Dr. Cheng is a nationally recognized leader in headache medicine, dedicated to advancing the field through research, clinical excellence, and federal advocacy. Her expertise is built on a foundation of elite training at Duke, University of Maryland, UCLA, and the Mayo Clinic.
She serves as an Associate Editor for Headache: The Journal of Head and Face Pain, a leading peer-reviewed publication in the field and the official journal of the American Headache Society. In this role, she helps curate and vet the latest clinical research and scientific breakthroughs that shape global standards of care.
Dr. Cheng is also a board member of The Headache Alliance, a nonprofit organization dedicated to improving the quality of life for the 40 million Americans living with headache disorders. She is an active advocate for this community and meets regularly with Congressional representatives to support patients with headache disorders. In this capacity, Dr. Cheng was an invited panelist for a Congressional briefing at the Capitol Hill Policy Forum for Headache on the Hill.
A committed educator and researcher, Dr. Cheng has authored numerous peer-reviewed publications and delivered presentations at national conferences. She previously served as an Assistant Professor of Neurology at the University of California, Irvine, where she was the founding Fellowship Director for Headache Medicine. She continues to shape the future of the specialty as a program director for HALO, an initiative mentoring the next generation of headache physicians.
Dr. Cheng founded Irvine Headache Care to create a practice centered on time, precision, and individualized care, where patients receive the attention and expertise their condition deserves. Her clinical expertise focuses on the most complex cases, including migraine, cluster headache, and trigeminal neuralgia, with a whole-person philosophy that looks beyond the prescription pad to restore function and help patients return to full, thriving lives.
Dr. Cheng’s Credentials
-
BS Biology - Duke University
MD - University of Maryland
Neurology Residency - UCLA *Chief Resident
Headache Fellowship -Mayo Clinic
-
American Academy of Neurology - Palatucci Advocacy Leadership
American Academy of Neurology Health Equity Scholar
American Headache Society - Emerging Leader
American Headache Society - Frontiers in Headache Research Award
American Headache Society Advocacy Scholar
Delegate of the International Headache Academy
UCLA Excellence in Teaching with Humanism Award
William Alexander Hammond Award for Excellence in Neurology
University of Maryland Certificate of Outstanding Achievement in Research
Duke Research Scholar
-
Cheng N, Halker-Singh R, Moskatel LS. Migraine Diagnostic Specificity and Treatment Patterns Across Asian Ethnic Subgroups: A National EHR and Census Study. Neurology – in peer review
Ong, B.; Khan, F.; Cheng, N.; Singh, R.B.H.; VanderPluym, J.H. Disparities in Headache Care and Research in Children and Adolescents: A Narrative Review. Curr. Pain Headache Rep. 2026, 30, https://doi.org/10.1007/s11916-026-01479-3.
Tram M, Cheng N, Jicha C. Differential impact of migraine with and without aura on severe maternal morbidity and postpartum readmissions: Insights from a national cohort study. Headache – Accepted
-
Cheng N, Olson PA. From Reader to Reviewer: First Steps in Peer Review for Residents. AAN Annual Meeting. April 2026
Cheng N. Capital Hill Policy Forum: Migraine & Headache Disorders: A Congressional Roadmap for Patient-Centered Care. February 2026.
Cheng N. Review of Headache Diagnosis and Treatment. Northridge Hospital Grand Rounds. October 2025.
Cheng N, Shirane R, Olson PA. Reviewers in Scientific Editing. American Headache Society Webinar. September and October 2025.
Cheng N, Anderson C, Zhang N, VanderPluym J, Starling A. Remote Electrical Neuromodulation for Reducing Procedural Pain in Patients with Chronic Migraine Receiving OnabotulinumtoxinA Injections: A Randomized Sham-Controlled Study. AHS Scientific Meeting. June 2025.
Cheng N, Early-Career Session: Making the First Moves as a Clinician Researcher. AHS Scientific Meeting June 2025
Cheng N, Halker-Singh R. Mind the Gap: Closing the Diversity Divide for Asian Americans in Neurology Research. AAN Annual Meeting April 2025
Cheng N. Unmasking IIH Without the Usual Signs. International Headache Academy, Los Angeles. January 2025.
Cheng N*, Traore F*. What They Did Not Teach You In Training: Navigating Academic vs. Private Practice Contracts. Webinar through the American Headache Society. Jan 14 2025.
Cheng N*, Traore F*. Navigating the Job Market in Headache Medicine: Choosing Between Academia vs. Private Practice. Webinar through the American Headache Society. October 2, 2024.
Cheng N, Halker-Singh R. Beyond Other: Exploring Representation of Minoritized Individuals in Headache Research. American Headache Society Scientific Meeting, San Diego. June 2024.
Cheng N. Exploring Representation of Minoritized Individuals in Headache Research. Mayo Clinic Grand Rounds, Scottsdale Arizona. May 2024.
Cheng N, Arca K. Autonomic Dysreflexia. International Headache Academy, Los Angeles. February 2024.
Cheng N. Bariatric Surgery: A Weighty Matter for Idiopathic Intracranial Hypertension. Mayo Clinic Grand Rounds, Scottsdale Arizona. December 2023.
Connerney M, Keselman I, Cheng N, Eslami V, Nuwer M. Clarity Interpretation of Ceribell Rapid Response Electroencephalography Use Shows Limited Influence on Patient Disposition and Outcome. UCLA Collin’s Day Research Symposium. May 2023
Connerney M, Cheng N, Gummi R. Seizure and Dural Sinus Thrombosis in setting of COVID-19 with 3 and 6 Month Outcomes after Long-Term Anticoagulation. UCLA Collin’s Day Research Symposium. May 2022
Cheng, N. SCA2 Presenting as Focal Dystonia, American Academy of Neurology Annual Meeting, Los Angeles CA, 2018
Azimzadeh A*, Cheng, N*. Multiplex profiling of plasma proteins after xenogeneic lung exposure. International Xenotransplantation Association Joint Congress. November 2015
Cheng, N. Mapping the Connection Between Urea and Capsule Production in Cryptococcus gattii, American Society of Microbiology Annual Meeting, Denver CO, 2013
Media
Orange County has no shortage of specialists, but headache medicine is a distinct subspecialty that most neurology practices are not equipped to handle at the level that complex or chronic cases require. UCNS certification in headache medicine requires a dedicated fellowship and a separate board examination. It is not a standard part of neurology training, and fewer than 600 physicians in the country hold it.
Why patients choose Irvine Headache Care
One of the country's top headache specialists, in your backyard
Until now, getting access to a UCNS-certified headache specialist has typically meant driving to Los Angeles or waiting months at a large academic medical center. At Irvine Headache Care new patients are typically seen within a week of contacting the practice.
Appointments built around your case, not a schedule
Your first visit is a full hour. Dr. Cheng will take a complete history, ask about things prior providers may not have thought to ask, and build a treatment plan specific to your case rather than your diagnosis code.
Every appointment is with Dr. Cheng
At most neurology practices, follow-up care gets handed off to nurse practitioners or covered by whoever is available. That does not happen here. Your case stays with one physician from the first visit forward.
No referral needed
Patients can contact Irvine Headache Care directly and are welcome to self-refer.
What People Are Saying
